Comparison between Healthcare Global IPO and Thyrocare Technologies IPO.
Healthcare Global IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Thyrocare Technologies IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Healthcare Global IPO is up to ₹649.64 Cr whereas the issue size of the Thyrocare Technologies IPO is up to ₹479.21 Cr. The final issue price of Healthcare Global IPO is ₹218.00 per share and of Thyrocare Technologies IPO is ₹446.00 per share.
| Healthcare Global IPO | Thyrocare Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹205.00 per share | ₹420.00 per share |
| Issue Price (Upper) | ₹218.00 per share | ₹446.00 per share |
| Issue Price (Final) | ₹218.00 per share | ₹446.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 65 shares | 33 shares |
| Fresh Issue Size | 1,16,00,000 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹252.88 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 1,82,00,000 shares | 1,07,44,708 shares |
| OFS Issue Size (Amount) | up to ₹396.76 Cr | up to ₹479.21 Cr |
| Issue Size Total | 2,98,00,000 shares | 1,07,44,708 shares |
| Issue Size Total (Amount) | up to ₹649.64 Cr | up to ₹479.21 Cr |
Healthcare Global IPO opens on Mar 16, 2016, while Thyrocare Technologies IPO opens on Apr 27, 2016. The closing date of Healthcare Global IPO and Thyrocare Technologies IPO is Mar 18, 2016, and Apr 29, 2016, respectively.
| Healthcare Global IPO | Thyrocare Technologies IPO | |
|---|---|---|
| Anchor Bid Date | Mar 15, 2016 | Apr 26, 2016 |
| Issue Open | Mar 16, 2016 | Apr 27, 2016 |
| Issue Close | Mar 18, 2016 | Apr 29, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Mar 30, 2016 | May 09, 2016 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Healthcare Global IPO P/E ratio is , as compared to Thyrocare Technologies IPO P/E ratio of .
| Healthcare Global IPO | Thyrocare Technologies IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 64.96 | |||||
| Promoter Shareholding (Post-Issue) | 63.96 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹1854.66 Cr. | ₹2396.07 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 17.37% |
In the Healthcare Global IPO Retail Individual Investors (RII) are offered 29,80,000 shares while in Thyrocare Technologies IPO retail investors are offered 29,80,000 shares. Qualified Institutional Buyers (QIB) are offered 89,40,000 shares in Healthcare Global IPO and 21,48,942 shares in Thyrocare Technologies IPO.
| Healthcare Global IPO | Thyrocare Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,34,10,000 shares | 32,23,411 shares |
| Market Maker Reservation | ||
| QIB | 89,40,000 shares | 21,48,942 shares |
| NII | 44,70,000 shares | 16,11,707 shares |
| RII | 29,80,000 shares | 37,60,648 shares |
| Employee | ||
| Others | ||
| Total | 2,98,00,000 shares | 1,07,44,708 shares |
Healthcare Global IPO subscribed 1.56x in total, whereas Thyrocare Technologies IPO subscribed 73.55x.
| Healthcare Global IPO | Thyrocare Technologies IPO | |
|---|---|---|
| QIB (times) | 2.36x | 73.18x |
| NII (times) | 0.43x | 225.30x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.83x | 8.73x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.56x | 73.55x |
